0.05Open0.05Pre Close0 Volume97 Open Interest2.50Strike Price0.00Turnover280.90%IV36.03%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0752Delta0.1101Gamma76.60Leverage Ratio-0.0168Theta0.0000Rho-5.76Eff Leverage0.0007Vega
Alto Neuroscience Stock Discussion
Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology
Wednesday, 11th December at 8:03 am
– Data generated from Alto's precision psychiatry platform and clinical-stage product candidates highlighted across three poster presentations and a panel discussion –
– New preclinical data from a reverse translation study demonstrates the link between the mechanism of ALTO-300 and the EEG biomarker used for...
<- Blackrock ->
$Alto Neuroscience (ANRO.US)$
sec.gov/Archive...
#myANROanalysis
Larger Image: tradingview.com...
$Alto Neuroscience (ANRO.US)$
No comment yet